0000-0002-0956-5329

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: No | Yes

No

Hämmig, Robert; Uhl, Alfred; Kuhlmann, Thomas (2014). Pro & Contra: Die aktuelle Leitliniendebatte kritisch hinterfragt. Suchttherapie, 15(3), pp. 101-103. Thieme 10.1055/s-0034-1386529

Hämmig, Robert (2014). Les hallucinogènes dans la thérapie des addictions. Dépendances(52), pp. 25-27. Addiction Suisse

Yes

Hämmig, Robert; Köhler, Wilfried; Bonorden-Kleij, Karin; Weber, Bernd; Lebentrau, Karin; Berthel, Toni; Babic-Hohnjec, Lucija; Vollmert, Christian; Höpner, Doris; Gholami, Najibulah; Verthein, Uwe; Haasen, Christian; Reimer, Jens; Ruckes, Christian (2014). Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence. Journal of substance abuse treatment, 47(4), pp. 275-281. Elsevier 10.1016/j.jsat.2014.05.012

Besson, Jacques; Beck, Thilo; Wiesbeck, Gerhard; Hämmig, Robert; Kuntz, André; Abid, Sami; Stohler, Rudolf (2014). Opioid maintenance therapy in Switzerland: an overview of the Swiss IMPROVE study. Swiss medical weekly, 144, w13933. EMH Schweizerischer Ärzteverlag 10.4414/smw.2014.13933

Hämmig, Robert (2014). Schadenminderung und substitutionsgestützte Behandlung. SuchtMagazin, 40(2), pp. 30-34. Infodrog

Hämmig, Robert (2014). Doppeldiagnosen: 20 Jahre Suchtdiskurs. SuchtMagazin, 40(1), pp. 8-10. Infodrog

Hämmig, Robert (2014). «Das Beste ist, Sie hören auf!» «Und das Zweitbeste?» Tabak-Schadenminderung. SuchtMagazin, 40(2), pp. 52-55. Infodrog

Hämmig, Robert (2014). OR07-4E-CIGS (VAPORIZERS): A public health opportunity that will be missed? Alcohol and alcoholism, 49(Supl 1), i45. Oxford University Press 10.1093/alcalc/agu053.34

Hämmig, Robert (2014). P-52 Slow-release oral morphine (srom) as further medication in opioid subtitution treatment (ost): Results from a registration study. Alcohol and alcoholism, 49(Suppl 1), i63. Oxford University Press 10.1093/alcalc/agu054.52

Provide Feedback